Dewpoint Therapeutics Secures Series D Funding to Pioneer Novel Gastric Cancer Therapy

Dewpoint Therapeutics, a U.S.-based biotechnology innovator, has announced the successful closure of its Series D financing round. As reported by thepharmaletter, Dewpoint Therapeutics is renowned for its pioneering work in…

Continue Reading Dewpoint Therapeutics Secures Series D Funding to Pioneer Novel Gastric Cancer Therapy

Calidi Biotherapeutics’ CLD-201 Secures FDA Fast Track for Innovative Glioblastoma Therapy

Calidi Biotherapeutics has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Fast Track designation to its experimental therapy, CLD-201 SuperNova, for the treatment of glioblastoma.…

Continue Reading Calidi Biotherapeutics’ CLD-201 Secures FDA Fast Track for Innovative Glioblastoma Therapy

And the Good News is . . .Cancer Survivors in the United States are Projected to Exceed 22 million people by 2035

Here's a more detailed explanation. The newest American Cancer Society study just released suggests that a diagnosis of cancer is no longer a death sentence. According to a recent U.S.…

Continue Reading And the Good News is . . .Cancer Survivors in the United States are Projected to Exceed 22 million people by 2035